InvestorsHub Logo
Followers 17
Posts 10900
Boards Moderated 0
Alias Born 03/11/2017

Re: None

Sunday, 10/28/2018 5:30:08 PM

Sunday, October 28, 2018 5:30:08 PM

Post# of 44784
US DoD to study PLX-R18 cell therapy to treat mustard gas injuries


PLX-R18 has so far been effective in recovering the bone marrow, leading to regeneration of progenitor cells and the three blood lineages, namely blood cells, red blood cells and platelets.

“Positive results from these studies may establish PLX-R18 as a medical countermeasure against a wide range of chemical, biological, radiological and nuclear (CBRN) threat agents.”



https://www.army-technology.com/news/us-dod-study-plx-r18-cell-therapy-treat-mustard-gas-injuries/